1Department of Pharmaceutical Chemistry, Sanjo College of Pharmaceutical Studies, Vellapara, Kuzhalmannam, Palakkad, Kerala - 678702, India
2Department of Pharmaceutical Chemistry, Chemists College of Pharmaceutical Sciences and Research, Puthencruz, Ernakulam, Kerala - 682308, India
3Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER)S.A.S. Nagar, Sector 67, S.A.S. Nagar, Mohali, Punjab-160062, India
*Corresponding Author E-mail: kn.arathi@gmail.com
Online Published on 12 October, 2023.
In this work we aimed to design synthesis and evaluate the N-Mannich bases of pyrazole. A novel series of N-Mannich bases of pyrazole analogues were designed and synthesized with an effort to overcome the increasing antibiotic resistance. Tyrosyl-tRNA synthetase (TyrRS) comprises an N-terminal domain, which has the fold of the class I aminoacyl-tRNA synthetases. Computational Autodock 4.2 tools will be employed in this study for docking of pyrazole ligand molecules against Tyrosyl-tRNA synthetase (TyrRS) of Escherichia coli (PDB code: 1x8x) and Staphylococcus aureus (PDB code: 1jil.pdb). Molinspiration server was used for lead optimization. The ligand molecules were subjected to molecular docking studies with enzyme Tyrosyl-tRNA synthetase. The molecular docking studies are supported to compare in-vitro antibacterial activity by the use of binding energy of the docked ligand molecules. The newly synthesized compounds were characterized by UV, IR and various physico-chemical methods. Further, the antibacterial activity of N-Mannich bases of pyrazole compounds were assessed with zone of inhibition by agar well diffusion method using gram negative bacterial strain Escherichia coli and gram-positive strain staphylococcus aureus. These same compounds were subjected to find the antifungal activity against Aspergillus fumigates and Aspergillus Niger.
Tyrosyl-tRNA synthetase, Pyrazole, Molecular docking, N-Mannich base, Antimicrobial activity